Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Yoshida

Showing results (311-320 of 332) with videos related to

Pageof 34
Sort By:
Scientific Reports|December 18, 2020
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibioticsMasakazu Morioka, Yoshihiro Takamura, Kazuki Nagai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2013
Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathyKeijiro Ishikawa, Shigeo Yoshida, Shintaro Nakao, et al.
Investigative Ophthalmology & Visual Science|June 17, 2025
Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular TreatmentRui Ji, Keijiro Ishikawa, Wei Tan, et al.
American Journal of Human Genetics|February 18, 2004
Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage diseaseGonçalo R Abecasis, Beverly M Yashar, Yu Zhao, et al.
Journal of Diabetes Investigation|March 27, 2024
Characterization of the visually impaired patients with diabetes mellitus in JapanYuka Sugihara, Yoshihiro Takamura, Yutaka Yamada, et al.
Investigative Ophthalmology & Visual Science|May 14, 2026
RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMDIori Wada, Keijiro Ishikawa, Muneo Yamaguchi, et al.
Human Molecular Genetics|February 8, 2017
Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese populationYukihide Momozawa, Masato Akiyama, Yoichiro Kamatani, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Journal of Human Genetics|July 29, 2018
Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degenerationMasato Akiyama, Atsushi Takahashi, Yukihide Momozawa, et al.
Journal of Clinical Medicine|November 26, 2022
Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in JapanRyohei Komori, Yoshihiro Takamura, Yutaka Yamada, et al.
Pageof 34

Showing results (311-320 of 332) with videos related to

Sort By:
Pageof 34
Scientific Reports|December 18, 2020
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibioticsMasakazu Morioka, Yoshihiro Takamura, Kazuki Nagai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2013
Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathyKeijiro Ishikawa, Shigeo Yoshida, Shintaro Nakao, et al.
Investigative Ophthalmology & Visual Science|June 17, 2025
Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular TreatmentRui Ji, Keijiro Ishikawa, Wei Tan, et al.
American Journal of Human Genetics|February 18, 2004
Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage diseaseGonçalo R Abecasis, Beverly M Yashar, Yu Zhao, et al.
Journal of Diabetes Investigation|March 27, 2024
Characterization of the visually impaired patients with diabetes mellitus in JapanYuka Sugihara, Yoshihiro Takamura, Yutaka Yamada, et al.
Investigative Ophthalmology & Visual Science|May 14, 2026
RPE With ROCK-Mediated Epithelial-Mesenchymal Transition as a Key Contributor of Subretinal Fibrosis in AMDIori Wada, Keijiro Ishikawa, Muneo Yamaguchi, et al.
Human Molecular Genetics|February 8, 2017
Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese populationYukihide Momozawa, Masato Akiyama, Yoichiro Kamatani, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Journal of Human Genetics|July 29, 2018
Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degenerationMasato Akiyama, Atsushi Takahashi, Yukihide Momozawa, et al.
Journal of Clinical Medicine|November 26, 2022
Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in JapanRyohei Komori, Yoshihiro Takamura, Yutaka Yamada, et al.
Pageof 34